The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is (7.62) USD. With the latest stock price at 172.26 USD, the upside of Repligen Corp based on DCF is -104.4%.
Based on the latest price of 172.26 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 104.4%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.1% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (18.97) - (4.18) | (7.62) |
| Upside | -111.0% - -102.4% | -104.4% |